AI-driven Patient-Selection For Preoperative Portal Vein Embolization For Patients With Colorectal Cancer Liver Metastases

To develop a machine-learning algorithm to improve hepatic resection selection for metastatic colorectal cancer patients by predicting post-PVE outcomes. This multicenter retrospective study (2000-2020) included 200 consecutive patients with CRC liver-metastases planned for PVE before surgery. Radio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of vascular and interventional radiology 2024-12
Hauptverfasser: Kuhn, Tom N, Engelhardt, William D, Kahl, Vinzent H, Alkukhun, Abedalrazaq, Gross, Moritz, Iseke, Simon, Onofrey, John, Covey, Anne, Camacho Vasquez, Juan C, Kawaguchi, Yoshikuni, Hasegawa, Kiyoshi, Odisio, Bruno C, Vauthey, Jean Nicolas, Antoch, Gerald, Chapiro, Julius, Madoff, David C
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To develop a machine-learning algorithm to improve hepatic resection selection for metastatic colorectal cancer patients by predicting post-PVE outcomes. This multicenter retrospective study (2000-2020) included 200 consecutive patients with CRC liver-metastases planned for PVE before surgery. Radiomic features and lab values were collected. Patient-specific eigenvalues for each liver shape were calculated using a statistical shape model approach. After semi-automatic segmentation and review by a board-certified radiologist, the data was split 70/30% for training and testing. Three machine learning algorithms predicting the total liver volume (TLV) after PVE, sufficient FLR%, and the kinetic growth rate % (KGR%) were trained with performance assessed using accuracy, sensitivty, specifity, AUC or RMSE. Significance between the internal and external test sets was assessed by the student's t-test. One institution was kept separate as an external testing set. A total of 114 (76m; 56y ±12) and 37 (19m; 50y ±11) patients met the inclusion criteria for the internal and external validation. Prediction accuracy (SD) and AUC (SD) for sufficient FLR% or liver growth potential (KGR%> 0%) were high in the internal testing set 0.91 (±0.01), 85.81% (±1.01%) or 0.66 (±0.03), 87.44% (±0.10%)). Similar results occurred on the external testing set 0.88 (±0.00), 79.66% (±0.60%) or 0.69 (±0.01), 72.06% (±0.30%)). TLV prediction showed a discrepancy of 12.56% (95% CI: ±4.20%, p=0.86) internally and 13.57% (95% CI: ±3.76%, p=0.91) externally. These machine learning-based models can help predict the FLR%, KGR%, and TLV as metrics for successful PVE.
ISSN:1051-0443
1535-7732
1535-7732
DOI:10.1016/j.jvir.2024.11.025